Cargando…
Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients
OBJECTIVE: To evaluate the psychometric properties of the Taiwan Chinese Version of the EORTC QLQ-PR25 health-related quality of life (HRQOL) questionnaire for patients with prostate cancer. METHODS: 135 prostate cancer patients were recruited in the urology outpatient clinic of a university teachin...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495729/ https://www.ncbi.nlm.nih.gov/pubmed/22901052 http://dx.doi.org/10.1186/1477-7525-10-96 |
_version_ | 1782249556506836992 |
---|---|
author | Chang, Yu-Jun Liang, Wen-Miin Wu, Hsi-Chin Lin, Hsueh-Chun Wang, Jong-Yi Li, Tsai-Chung Yeh, Yi-Chun Chang, Chih-Hung |
author_facet | Chang, Yu-Jun Liang, Wen-Miin Wu, Hsi-Chin Lin, Hsueh-Chun Wang, Jong-Yi Li, Tsai-Chung Yeh, Yi-Chun Chang, Chih-Hung |
author_sort | Chang, Yu-Jun |
collection | PubMed |
description | OBJECTIVE: To evaluate the psychometric properties of the Taiwan Chinese Version of the EORTC QLQ-PR25 health-related quality of life (HRQOL) questionnaire for patients with prostate cancer. METHODS: 135 prostate cancer patients were recruited in the urology outpatient clinic of a university teaching hospital. Each patient completed the EORTC QLQ-PR25 at every clinic visit between 2004 and 2008, totaling 633 assessments. Confirmatory factor analysis and Rasch analysis were used to evaluate the domain- and item-level psychometric properties. RESULTS: The results supported the unidimensionality of each of the four EORTC QLQ-PR25 domains (urinary, bowel, and hormonal-treatment-related symptoms, and sexual functioning). Item calibrations for each domain were found invariant across the three assessment time periods. The item-person maps showed 71.3% of item coverage for the urinary symptoms domain and 13–42.7% for the other three domains. CONCLUSIONS: The Taiwan Chinese Version of the EORTC QLQ-PR25 questionnaire is reliable and can be used to measure HRQOL over time. Adding new items to each domain may improve its clinical content coverage and measurement precision. |
format | Online Article Text |
id | pubmed-3495729 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34957292012-11-13 Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients Chang, Yu-Jun Liang, Wen-Miin Wu, Hsi-Chin Lin, Hsueh-Chun Wang, Jong-Yi Li, Tsai-Chung Yeh, Yi-Chun Chang, Chih-Hung Health Qual Life Outcomes Research OBJECTIVE: To evaluate the psychometric properties of the Taiwan Chinese Version of the EORTC QLQ-PR25 health-related quality of life (HRQOL) questionnaire for patients with prostate cancer. METHODS: 135 prostate cancer patients were recruited in the urology outpatient clinic of a university teaching hospital. Each patient completed the EORTC QLQ-PR25 at every clinic visit between 2004 and 2008, totaling 633 assessments. Confirmatory factor analysis and Rasch analysis were used to evaluate the domain- and item-level psychometric properties. RESULTS: The results supported the unidimensionality of each of the four EORTC QLQ-PR25 domains (urinary, bowel, and hormonal-treatment-related symptoms, and sexual functioning). Item calibrations for each domain were found invariant across the three assessment time periods. The item-person maps showed 71.3% of item coverage for the urinary symptoms domain and 13–42.7% for the other three domains. CONCLUSIONS: The Taiwan Chinese Version of the EORTC QLQ-PR25 questionnaire is reliable and can be used to measure HRQOL over time. Adding new items to each domain may improve its clinical content coverage and measurement precision. BioMed Central 2012-08-20 /pmc/articles/PMC3495729/ /pubmed/22901052 http://dx.doi.org/10.1186/1477-7525-10-96 Text en Copyright ©2012 Chang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Chang, Yu-Jun Liang, Wen-Miin Wu, Hsi-Chin Lin, Hsueh-Chun Wang, Jong-Yi Li, Tsai-Chung Yeh, Yi-Chun Chang, Chih-Hung Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients |
title | Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients |
title_full | Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients |
title_fullStr | Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients |
title_full_unstemmed | Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients |
title_short | Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients |
title_sort | psychometric evaluation of the taiwan chinese version of the eortc qlq-pr25 for hrqol assessment in prostate cancer patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495729/ https://www.ncbi.nlm.nih.gov/pubmed/22901052 http://dx.doi.org/10.1186/1477-7525-10-96 |
work_keys_str_mv | AT changyujun psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients AT liangwenmiin psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients AT wuhsichin psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients AT linhsuehchun psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients AT wangjongyi psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients AT litsaichung psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients AT yehyichun psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients AT changchihhung psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients |